[go: up one dir, main page]

SE7614539L - Forfarande for framstellning av karbostyrilderivat med terapeutisk verkan - Google Patents

Forfarande for framstellning av karbostyrilderivat med terapeutisk verkan

Info

Publication number
SE7614539L
SE7614539L SE7614539A SE7614539A SE7614539L SE 7614539 L SE7614539 L SE 7614539L SE 7614539 A SE7614539 A SE 7614539A SE 7614539 A SE7614539 A SE 7614539A SE 7614539 L SE7614539 L SE 7614539L
Authority
SE
Sweden
Prior art keywords
group
hydrogen atom
cycloalkylalkanoyl
phenylalkylcarbonyl
formula
Prior art date
Application number
SE7614539A
Other languages
English (en)
Other versions
SE434395B (sv
Inventor
K Nakagawa
E Yo
S Yoshizaki
S Tamada
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of SE7614539L publication Critical patent/SE7614539L/sv
Publication of SE434395B publication Critical patent/SE434395B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C07D215/32—Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7614539A 1976-10-08 1976-12-23 Analogiforfarande for framstellning av karbostyrilderivat med terapeutisk verkan SE434395B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP51121423A JPS609713B2 (ja) 1976-10-08 1976-10-08 カルボスチリル誘導体

Publications (2)

Publication Number Publication Date
SE7614539L true SE7614539L (sv) 1978-04-09
SE434395B SE434395B (sv) 1984-07-23

Family

ID=14810767

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7614539A SE434395B (sv) 1976-10-08 1976-12-23 Analogiforfarande for framstellning av karbostyrilderivat med terapeutisk verkan

Country Status (10)

Country Link
US (1) US4223137A (sv)
JP (1) JPS609713B2 (sv)
BE (1) BE849794A (sv)
CA (1) CA1074801A (sv)
CH (1) CH618431A5 (sv)
DE (1) DE2658544C2 (sv)
FR (1) FR2378521A1 (sv)
GB (1) GB1540628A (sv)
NL (1) NL174041C (sv)
SE (1) SE434395B (sv)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
US4322425A (en) * 1980-03-14 1982-03-30 Otsuka Pharmaceutical Co., Ltd. Compositions for treating glaucoma
FI77852C (sv) * 1981-02-17 1989-05-10 Otsuka Pharma Co Ltd Förfarande för framställning av nya, såsom hjärtmediciner användbara s ubstituerade amid- och (mättad heterocykel)karbonylkarbostyrilderivat.
US4456757A (en) * 1981-03-20 1984-06-26 Asahi Kasei Kogyo Kabushiki Kaisha Isoquinolinesulfonyl derivatives and process for the preparation thereof
ATE27451T1 (de) * 1981-03-24 1987-06-15 Ciba Geigy Ag Acyl-chinolinonderivate, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische praeparate und ihre verwendung.
GB8334494D0 (en) * 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
JPS60173736U (ja) * 1984-04-25 1985-11-18 株式会社昭和製作所 緩衝器用サブタンク
JPS61191767A (ja) * 1985-02-20 1986-08-26 辻本　夘太郎 植物張り家屋
JPS62113672A (ja) * 1985-11-12 1987-05-25 本田技研工業株式会社 リヤクツシヨン用リザ−ブタンク
JPS6348401U (sv) * 1986-09-17 1988-04-01
JPS63106132A (ja) * 1986-10-24 1988-05-11 Mazda Motor Corp 車両のサスペンシヨン装置
US4687776A (en) * 1986-10-24 1987-08-18 Warner-Lambert Company Drug stabilization
JPS6374545U (sv) * 1986-10-31 1988-05-18
JPS6417047U (sv) * 1987-07-21 1989-01-27
US4894219A (en) * 1988-03-29 1990-01-16 University Of Florida Beta-agonist carbostyril derivatives, assay method and pharmacological composition
JPH026831U (sv) * 1988-06-28 1990-01-17
US6653323B2 (en) 2001-11-13 2003-11-25 Theravance, Inc. Aryl aniline β2 adrenergic receptor agonists
TWI249515B (en) 2001-11-13 2006-02-21 Theravance Inc Aryl aniline beta2 adrenergic receptor agonists
US20030229058A1 (en) 2001-11-13 2003-12-11 Moran Edmund J. Aryl aniline beta2 adrenergic receptor agonists
US6747043B2 (en) 2002-05-28 2004-06-08 Theravance, Inc. Alkoxy aryl β2 adrenergic receptor agonists
US20070060748A1 (en) * 2002-11-27 2007-03-15 Hamilton Gregory S Compounds with mixed pde-inhibitory and beta-adrenergic antagonist or partial agonist activity for treatment of heart failure
TW200526547A (en) 2003-09-22 2005-08-16 Theravance Inc Amino-substituted ethylamino β2 adrenergic receptor agonists
TW200531692A (en) 2004-01-12 2005-10-01 Theravance Inc Aryl aniline derivatives as β2 adrenergic receptor agonists
FR2869893B1 (fr) * 2004-05-06 2006-07-28 Rhodia Chimie Sa Nouveaux granules de phosphates de calcium de type hydroxyapatite, leur procede de preparation et leurs applications
JP2007537187A (ja) * 2004-05-13 2007-12-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 呼吸器疾患の治療においてβアゴニストとして使用するためのヒドロキシ置換ベンゾ縮合ヘテロ環化合物
US7307076B2 (en) 2004-05-13 2007-12-11 Boehringer Ingelheim International Gmbh Beta agonists for the treatment of respiratory diseases
BRPI0511695A (pt) 2004-06-03 2008-01-08 Theravance Inc agonistas de receptor (beta)2 adrenérgico diamina
EP1786762A2 (en) 2004-09-10 2007-05-23 Theravance, Inc. Amidine substituted aryl aniline compounds
GB0624757D0 (en) * 2006-12-12 2007-01-17 Sosei R & D Ltd Novel compounds
WO2014102594A2 (en) 2012-12-27 2014-07-03 Purdue Pharma L.P. Substituted benzimidazole-type piperidine compounds and uses thereof
WO2014108449A1 (en) 2013-01-08 2014-07-17 Atrogi Ab A screening method, a kit, a method of treatment and a compound for use in a method of treatment
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201903832D0 (en) 2019-03-20 2019-05-01 Atrogi Ab New compounds and methods
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses
CN120583945A (zh) 2023-01-20 2025-09-02 阿托基公司 用于治疗或预防肌肉消耗的β2-肾上腺素能受体激动剂
GB202302225D0 (en) 2023-02-16 2023-04-05 Atrogi Ab New medical uses
GB202303229D0 (en) 2023-03-06 2023-04-19 Atrogi Ab New medical uses
GB202403169D0 (en) 2024-03-05 2024-04-17 Atrogi Ab New medical uses
WO2025238248A1 (en) 2024-05-17 2025-11-20 Atrogi Ab USE OF β2-ADRENERGIC RECEPTOR AGONISTS IN TREATING MUSCLE WASTING

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3975391A (en) * 1973-12-26 1976-08-17 Otsuka Pharmaceutical Company Limited 5-[1-Hydroxy-2-(substituted-amino)]ethyl-8-hydroxy-3,4-dihydrocarbostyril derivatives
JPS539227B2 (sv) * 1973-12-26 1978-04-04
US4026897A (en) * 1974-01-31 1977-05-31 Otsuka Pharmaceutical Company 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-hydroxycarbostyril derivatives
US4022784A (en) * 1974-01-31 1977-05-10 Otsuka Pharmaceutical Company Limited 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-substituted-carbostyril and -3,4-dihydrocarbostyril derivatives
US3994901A (en) * 1974-06-13 1976-11-30 Otsuka Pharmaceutical Company Limited 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-hydroxy-3,4-dihydrocarbostyril derivatives
FI58329C (fi) * 1974-11-08 1981-01-12 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av i 8-staellning substituerade 5-(3'-alkylamino-2'-hydroxi)propoxi-3,4-dihydrokarbostyrilderivat

Also Published As

Publication number Publication date
CH618431A5 (sv) 1980-07-31
NL174041B (nl) 1983-11-16
NL174041C (nl) 1984-04-16
DE2658544C2 (de) 1985-10-03
BE849794A (fr) 1977-04-15
GB1540628A (en) 1979-02-14
US4223137A (en) 1980-09-16
FR2378521B1 (sv) 1979-06-29
FR2378521A1 (fr) 1978-08-25
SE434395B (sv) 1984-07-23
JPS609713B2 (ja) 1985-03-12
DE2658544A1 (de) 1978-04-13
NL7614329A (nl) 1978-04-11
AU2085576A (en) 1978-04-06
JPS5346983A (en) 1978-04-27
CA1074801A (en) 1980-04-01

Similar Documents

Publication Publication Date Title
SE7614539L (sv) Forfarande for framstellning av karbostyrilderivat med terapeutisk verkan
ES8102107A1 (es) Un procedimiento para la obtencion de un derivado de tiazo- lidina
NO165145C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1h-imidazo-(4,5-c)-kinolin-4-aminderivater.
ES474215A1 (es) Procedimiento para la preparacion de derivados imidazolile- tiloxialcoxilicos y sus analogos con agrupacion tio
DK0615549T3 (da) Fremgangsmåde til fremstilling af farmaceutisk aktive thiazolidin- eller oxazolidinforbindelser med en gærreduktase
SE7509861L (sv) Forfarande for framstellning av n-acylamino-alfa-arylacetamido-cefalosporiner
ES8800142A1 (es) Un procedimiento para preparar un derivado de semicarbazida
ES466143A1 (es) Un procedimiento de preparacion de nuevas imidazoquinoleinas
DK138488A (da) Imidazolderivater
DK151803C (da) Analogifremgangsmaade til fremstilling af n-pyrrolylpyridazinaminderivater eller farmaceutisk acceptable salte deraf
SE7703000L (sv) Forfarande for framstellning av karbostyrilderivat
DE3869163D1 (de) Benzylidenamino-, benzylamino- und benzoylamino-imidazolderivate.
KR880011122A (ko) 4-티오퀴나졸린 유도체, 이의 제조방법 및 약제학적 조성물
SE7603951L (sv) Forfarande for framstellning av 7-alfa-(4-hydroci-1,5-nafthydrin-3karbonamido)alfa-fenylacetamido-cefalosporinderivat
GB1142508A (en) Pyrrole derivatives
CA2053705A1 (en) Piperazine derivatives
SE8703494D0 (sv) Mellanprodukter anvendbara vid framstellning av 2-tiofen-ettiksyraderivat
SE7413858L (sv)
IE44681L (en) Benzofuran derivatives
IE40836B1 (en) Benzoxazoline derivatives,their preparation and use as plant growth regulants
ES412484A1 (es) Procedimiento para la preparacion de derivados carbostirili-cos.
ES435959A1 (es) Un procedimiento para obtener un derivado de pirido (3, 4-d)piridizina.
GB1283187A (en) Improvements in or relating to rifamycin derivatives and the preparation thereof
GB1102765A (en) Ergolenyl-carboxylic acid amides
GB1072167A (en) Improvements in or relating to oxa-1-azabicycloalkane derivatives

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7614539-0

Effective date: 19910704

Format of ref document f/p: F